{
  "id": "cluster_33_doc4",
  "content": "Clinical trial NCT04883421 enrolled 23 participants with rare metabolic disorders from the Albany region, focusing on long-term outcomes of combined enzyme replacement and dietary therapies. Interim results show 78% of participants (median age 10) maintained stable biomarker levels. Study coordinators require participating insurers to share claims data through secure portal RS-Connect using authorization code AC883-45NY.",
  "metadata": {
    "format": "research_note"
  }
}